FI951535L - Immunogeeninen meningokokki -LPS ja siitä saadut ulkomembraanirakkulat ja rokote - Google Patents
Immunogeeninen meningokokki -LPS ja siitä saadut ulkomembraanirakkulat ja rokote Download PDFInfo
- Publication number
- FI951535L FI951535L FI951535A FI951535A FI951535L FI 951535 L FI951535 L FI 951535L FI 951535 A FI951535 A FI 951535A FI 951535 A FI951535 A FI 951535A FI 951535 L FI951535 L FI 951535L
- Authority
- FI
- Finland
- Prior art keywords
- immunogenic
- vaccine
- derived therefrom
- outer membrane
- membrane vesicles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL9201716A NL9201716A (nl) | 1992-10-02 | 1992-10-02 | Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat. |
PCT/NL1993/000163 WO1994008021A1 (fr) | 1992-10-02 | 1993-07-30 | Lipopolysaccharide meningococcique immunogenique ainsi que vesicules de membrane externe et vaccins obtenus |
Publications (2)
Publication Number | Publication Date |
---|---|
FI951535A0 FI951535A0 (fi) | 1995-03-31 |
FI951535L true FI951535L (fi) | 1995-06-01 |
Family
ID=19861338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI951535A FI951535L (fi) | 1992-10-02 | 1995-03-31 | Immunogeeninen meningokokki -LPS ja siitä saadut ulkomembraanirakkulat ja rokote |
Country Status (14)
Country | Link |
---|---|
US (1) | US5705161A (fr) |
EP (1) | EP0680512B1 (fr) |
JP (1) | JPH08501940A (fr) |
AT (1) | ATE364702T1 (fr) |
AU (1) | AU684720B2 (fr) |
CA (1) | CA2146145C (fr) |
DE (1) | DE69334147T2 (fr) |
DK (1) | DK0680512T3 (fr) |
ES (1) | ES2289739T3 (fr) |
FI (1) | FI951535L (fr) |
NL (1) | NL9201716A (fr) |
NO (1) | NO321651B1 (fr) |
PT (1) | PT680512E (fr) |
WO (1) | WO1994008021A1 (fr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
AU707131B2 (en) * | 1995-08-04 | 1999-07-01 | University Of Guelph | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
US20020028215A1 (en) | 1999-08-09 | 2002-03-07 | Jagath L. Kadurugamuwa | Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same |
US6872398B2 (en) * | 1995-12-22 | 2005-03-29 | The United States Of America As Represented By The Secretary Of The Army | Conjugate vaccine against gram-negative bacterial infections |
US6645503B1 (en) * | 1998-03-10 | 2003-11-11 | Wyeth Holdings Corporation | Antigenic conjugates of conserved lipopolysaccharides of gram negative bacteria |
US10967045B2 (en) | 1998-11-02 | 2021-04-06 | Secretary of State for Health and Social Care | Multicomponent meningococcal vaccine |
GB9823978D0 (en) * | 1998-11-02 | 1998-12-30 | Microbiological Res Authority | Multicomponent meningococcal vaccine |
US6514948B1 (en) * | 1999-07-02 | 2003-02-04 | The Regents Of The University Of California | Method for enhancing an immune response |
US6531131B1 (en) | 1999-08-10 | 2003-03-11 | The United States Of America As Represented By The Department Of Health And Human Services | Conjugate vaccine for Neisseria meningitidis |
US7585510B1 (en) | 1999-09-30 | 2009-09-08 | Isis Innovation Limited | Vaccine |
AU2001280883A1 (en) * | 2000-07-27 | 2002-02-13 | The Children's Hospital & Research Center At Oakland | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
CA2479879A1 (fr) * | 2002-03-20 | 2003-10-02 | Emory University | Mutants de neisseria, lipooligosaccharides et compositions immunogenes |
MY149591A (en) | 2002-08-02 | 2013-09-13 | Glaxosmithkline Biolog Sa | Vaccines comprising l2 and/or l3 los from neisseria |
GB0220194D0 (en) | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
SI2351579T1 (sl) | 2002-10-11 | 2017-05-31 | Glaxosmithkline Biologicals Sa | Polipeptidna cepiva za široko zaščito proti hipervirulentnim meningokoknim linijam |
ATE466875T1 (de) | 2002-11-15 | 2010-05-15 | Novartis Vaccines & Diagnostic | Unerwartete oberflächenproteine in neisseria meningitidis |
GB0227346D0 (en) | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
CA2514328C (fr) | 2003-01-30 | 2020-01-14 | Chiron Srl | Vaccins injectables contre les multiples serogroupes du meningocoque |
GB0323103D0 (en) | 2003-10-02 | 2003-11-05 | Chiron Srl | De-acetylated saccharides |
GB0408977D0 (en) | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
US7537766B2 (en) * | 2004-08-30 | 2009-05-26 | Wyeth | Neisseria meningitidis inner core lipo-oligosaccharide epitopes, multivalent conjugates thereof and immunogenic compositions thereof |
GB0424092D0 (en) | 2004-10-29 | 2004-12-01 | Chiron Srl | Immunogenic bacterial vesicles with outer membrane proteins |
NZ555937A (en) | 2005-01-27 | 2009-05-31 | Childrens Hosp & Res Ct Oak | GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis |
GB0524066D0 (en) | 2005-11-25 | 2006-01-04 | Chiron Srl | 741 ii |
US20090246224A1 (en) | 2006-06-12 | 2009-10-01 | Nathalie Devos | Vaccine |
WO2009104097A2 (fr) | 2008-02-21 | 2009-08-27 | Novartis Ag | Polypeptides fhbp à méningocoques |
MX2010012999A (es) * | 2008-05-30 | 2012-03-07 | U S A As Represented By The Secretary Of The Army On Behalf Of Walter Reed Army | Vacuna de vesícula de membrana externa nativa multivalente del meningococo, método para su fabricación y uso. |
CA2756533A1 (fr) | 2009-03-24 | 2010-09-30 | Novartis Ag | Combinaisons de proteine liant le facteur h de meningocoque et de conjugues de saccharide de pneumocoque |
HUE049695T2 (hu) | 2009-03-24 | 2020-10-28 | Glaxosmithkline Biologicals Sa | Adjuváló H meningococcus faktort kötõ fehérje |
AU2010247254A1 (en) * | 2009-05-14 | 2012-01-12 | Sanofi Pasteur | Menigococcus vaccine containing lipooligosaccharide (LOS) from modified strains of L6 immunotype Neisseria meningitidis |
JP5536765B2 (ja) * | 2009-05-20 | 2014-07-02 | 国立大学法人鳥取大学 | 部分糖鎖エピトープを用いた、病原性ナイセリア属細菌感染の検出方法およびそれら細菌に対するワクチン |
US20110076300A1 (en) | 2009-08-27 | 2011-03-31 | Mariagrazia Pizza | Hybrid Polypeptides Including Meningococcal fHBP Sequences |
CN102740882A (zh) | 2009-08-27 | 2012-10-17 | 诺华有限公司 | 含有铝、寡核苷酸和聚阳离子的佐剂 |
AU2010302344A1 (en) | 2009-09-30 | 2012-04-26 | Novartis Ag | Expression of meningococcal fhbp polypeptides |
JP5960055B2 (ja) | 2009-10-27 | 2016-08-02 | ノバルティス アーゲー | 改変髄膜炎菌fHBPポリペプチド |
EP2547357A1 (fr) | 2010-03-18 | 2013-01-23 | Novartis AG | Vaccins adjuvantés contre le méningocoque de sérogroupe b |
US10478483B2 (en) | 2010-06-25 | 2019-11-19 | Glaxosmithkline Biologicals Sa | Combinations of meningococcal factor H binding proteins |
BR112014016223A8 (pt) | 2011-12-29 | 2017-07-04 | Novartis Ag | combinações adjuvantes de proteínas de ligação de fator h meningocócico |
KR20160127104A (ko) | 2014-02-28 | 2016-11-02 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 변형된 수막구균 fhbp 폴리펩티드 |
GB201712824D0 (en) | 2017-08-10 | 2017-09-27 | Glaxosmithkline Biologicals Sa | Multi-functionalized nOMV Conjugates |
JP2021533834A (ja) * | 2018-08-14 | 2021-12-09 | エバーサイト・ゲーエムベーハー | 標的特異的細胞外小胞 |
EP4277654A1 (fr) | 2021-01-18 | 2023-11-22 | Conserv Bioscience Limited | Compositions immunogènes de coronavirus, méthodes et utilisations de celles-ci |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990006696A2 (fr) * | 1988-12-19 | 1990-06-28 | Praxis Biologics, Inc. | Vaccin meningocoque de la proteine de la membrane externe de la classe 1 |
NL9101359A (nl) * | 1991-08-07 | 1993-03-01 | Nederlanden Staat | Nieuw saccharide-peptide-conjugaat, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk saccharide-peptide-conjugaat omvat. |
-
1992
- 1992-10-02 NL NL9201716A patent/NL9201716A/nl not_active Application Discontinuation
-
1993
- 1993-07-30 CA CA002146145A patent/CA2146145C/fr not_active Expired - Lifetime
- 1993-07-30 EP EP93921120A patent/EP0680512B1/fr not_active Expired - Lifetime
- 1993-07-30 DK DK93921120T patent/DK0680512T3/da active
- 1993-07-30 JP JP6508917A patent/JPH08501940A/ja active Pending
- 1993-07-30 AU AU48351/93A patent/AU684720B2/en not_active Ceased
- 1993-07-30 AT AT93921120T patent/ATE364702T1/de active
- 1993-07-30 DE DE69334147T patent/DE69334147T2/de not_active Expired - Lifetime
- 1993-07-30 US US08/411,727 patent/US5705161A/en not_active Expired - Lifetime
- 1993-07-30 WO PCT/NL1993/000163 patent/WO1994008021A1/fr active IP Right Grant
- 1993-07-30 ES ES93921120T patent/ES2289739T3/es not_active Expired - Lifetime
- 1993-07-30 PT PT93921120T patent/PT680512E/pt unknown
-
1995
- 1995-03-28 NO NO19951181A patent/NO321651B1/no not_active IP Right Cessation
- 1995-03-31 FI FI951535A patent/FI951535L/fi unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994008021A1 (fr) | 1994-04-14 |
DE69334147D1 (de) | 2007-07-26 |
NO321651B1 (no) | 2006-06-19 |
NO951181D0 (no) | 1995-03-28 |
AU684720B2 (en) | 1998-01-08 |
NL9201716A (nl) | 1994-05-02 |
JPH08501940A (ja) | 1996-03-05 |
ATE364702T1 (de) | 2007-07-15 |
CA2146145A1 (fr) | 1994-04-14 |
FI951535A0 (fi) | 1995-03-31 |
NO951181L (no) | 1995-06-01 |
PT680512E (pt) | 2007-09-25 |
EP0680512A1 (fr) | 1995-11-08 |
ES2289739T3 (es) | 2008-02-01 |
CA2146145C (fr) | 2009-10-27 |
AU4835193A (en) | 1994-04-26 |
DE69334147T2 (de) | 2008-02-14 |
DK0680512T3 (da) | 2007-10-01 |
US5705161A (en) | 1998-01-06 |
EP0680512B1 (fr) | 2007-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI951535L (fi) | Immunogeeninen meningokokki -LPS ja siitä saadut ulkomembraanirakkulat ja rokote | |
DK0812593T4 (da) | Vaccinepræparater indeholdende 3-O-deacyleret monophosphoryllipid-A | |
DK0504202T3 (da) | Forbedret meningokok-polysaccharid-konjugat vaccine | |
KR900011476A (ko) | 백신 제제 | |
FI944052L (fi) | Oraalinen rokote | |
ATE186541T1 (de) | Quillajasaponin-zusatz und diesen enthaltende impfstoffformulierung | |
FI930266L (fi) | Vateriitti ja menetelmä sen valmistamiseksi | |
FI916112L (fi) | Hierron apuaine ja sitä käyttävä hiertomenetelmä | |
AU8684991A (en) | Novel muramyldipeptide derivatives and influenza vaccine comprising the derivatives | |
NO895012L (no) | Fremgangsmaate for fremstilling av varige titandioxydpigmenter. | |
NO972219D0 (no) | Immunogenpreparater | |
BR9707418A (pt) | Preparação medicinal e um método de ação medicinal sobre o organismo humano | |
DK232687D0 (da) | Kosmetisk praeparat mod rynker | |
BR9500296A (pt) | Solução aquosa de lipossomas e preparação de lipossomas liofilizados | |
KR930702527A (ko) | gp160의 유도체 및 보조약을 함유하는 gp160 또는 그의 유도체를 기재로하는 백신 | |
DE69535981D1 (de) | Reovirus Stamm 2177 und diesen enthaltende Vakzine | |
AU8204887A (en) | Conjugate vaccine | |
FI945227L (fi) | Sykliset heksapeptidit, niiden valmistus ja käyttö | |
AU3038697A (en) | Meningococcal vaccine | |
FR2715304B1 (fr) | Vaccin anti-allergique. | |
HU9303207D0 (en) | Liposomal polysaccharide vaccines | |
FI971403L (fi) | Menetelmä voimistettujen antigeenisten enteeristen bakteerien ja niitä sisältävien rokotteiden tuottamiseksi | |
FI961869A0 (fi) | Rokotteen suunnittelu ja valmistus | |
IL98839A0 (en) | Vaccines comprising protein of the outer membrane of neisseria meningitidis | |
IL115197A0 (en) | Vaccine preparations |